Akums Drugs and Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
16,127
- Stock Symbol
-
544222
- Investments
-
3
- Share Price
-
$9.82
- (As of Monday Closing)
Akums Drugs and Pharmaceuticals General Information
Description
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).
Contact Information
Website
www.akums.inCorporate Office
- 304, Mohan Place, L.S.C.
- Block-C, Saraswati Vihar
- Delhi, 110034
- India
Corporate Office
- 304, Mohan Place, L.S.C.
- Block-C, Saraswati Vihar
- Delhi, 110034
- India
Akums Drugs and Pharmaceuticals Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $9.82 | $9.96 | $8.62 - $14.01 | $1.55B | 157M | 92K |
Akums Drugs and Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| Revenue | 485,552 | 485,552 | 432,734 | 489,458 |
| EBITDA | 14,328 | 14,328 | 37,510 | (11,651) |
| Net Income | 95 | 95 | 12,182 | (33,671) |
| Total Assets | 421,659 | 421,659 | 397,867 | 404,737 |
| Total Debt | 67,778 | 67,778 | 75,406 | 52,089 |
Akums Drugs and Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Akums Drugs and Pharmaceuticals Comparisons
Industry
Financing
Details
Akums Drugs and Pharmaceuticals Competitors (31)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Panacea Biotec | Corporation | New Delhi, India | ||||
| Novartis India | Corporation | Mumbai, India | ||||
| Jubilant Pharmova | Corporation | Noida, India | ||||
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
| Farbe Firma Pvt. | Corporation | Ankleshwar, India |
Akums Drugs and Pharmaceuticals Executive Team (11)
| Name | Title | Board Seat |
|---|---|---|
| O. Singh | Chief Executive Officer | |
| Sanjay Sinha | Board Member & President, Operations | |
| Sumeet Sood | Chief Financial Officer | |
| Gopal Solanki | Co-Chief Operating Officer | |
| Ishu Giri | Co-Chief Operating Officer |
Akums Drugs and Pharmaceuticals Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Akums Drugs and Pharmaceuticals | Co-Founder & Chairman | ||
| Self | Board Member | ||
| Self | Board Member | ||
| Self | Board Member | ||
| Akums Drugs and Pharmaceuticals | Board Member & President, Operations |
Akums Drugs and Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Akums Drugs and Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Akums Drugs and Pharmaceuticals Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Akums Drugs and Pharmaceuticals (Formulation Facility in Baddi) | 05-Dec-2023 | Buildings and Property | |||
| Ankur Drugs and Pharmaceuticals (Facility Located in Himachal Pradesh) | 26-Apr-2022 | Buildings and Property | |||
| Parabolic Drugs | 01-Apr-2019 | Merger/Acquisition | Pharmaceuticals |
Akums Drugs and Pharmaceuticals Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Parabolic Drugs | Pharmaceuticals | Chandigarh, India |
Akums Drugs and Pharmaceuticals FAQs
-
When was Akums Drugs and Pharmaceuticals founded?
Akums Drugs and Pharmaceuticals was founded in 2004.
-
Who is the founder of Akums Drugs and Pharmaceuticals?
Sandeep Jain, Sanjeev Jain, and D.C. Jain are the founders of Akums Drugs and Pharmaceuticals.
-
Who is the CEO of Akums Drugs and Pharmaceuticals?
O. Singh is the CEO of Akums Drugs and Pharmaceuticals.
-
Where is Akums Drugs and Pharmaceuticals headquartered?
Akums Drugs and Pharmaceuticals is headquartered in Delhi, India.
-
What is the size of Akums Drugs and Pharmaceuticals?
Akums Drugs and Pharmaceuticals has 16,127 total employees.
-
What industry is Akums Drugs and Pharmaceuticals in?
Akums Drugs and Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Akums Drugs and Pharmaceuticals a private or public company?
Akums Drugs and Pharmaceuticals is a Public company.
-
What is Akums Drugs and Pharmaceuticals’s stock symbol?
The ticker symbol for Akums Drugs and Pharmaceuticals is 544222.
-
What is the current stock price of Akums Drugs and Pharmaceuticals?
As of 07-Oct-2024 the stock price of Akums Drugs and Pharmaceuticals is $9.82.
-
What is the current market cap of Akums Drugs and Pharmaceuticals?
The current market capitalization of Akums Drugs and Pharmaceuticals is $1.55B.
-
What is Akums Drugs and Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Akums Drugs and Pharmaceuticals is $486M.
-
Who are Akums Drugs and Pharmaceuticals’s competitors?
Panacea Biotec, Novartis India, Jubilant Pharmova, GlaxoSmithKline Consumer Nigeria, and Farbe Firma Pvt. are some of the 31 competitors of Akums Drugs and Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
